response preceded, and FTL followed that of HO-1. LCN2 elevation supported not only its role in iron transport, but also mediation of matrix metalloproteinase 9 (MMP9) activity.
ABBREVIATIONS
TBI, traumatic brain injury; FPI, moderate midline fluid percussion injury; CCI, controlled cortical impact injury; WB, Western Blot; IHC, immunohistochemistry; HO-1, HO-2, heme oxygenase 1,2; LCN2, lipocalin 2; MMP-9, matrix metalloproteinase 9; MMP-2, matrix metalloproteinase 2; FTL, ferritin; GFAP, glial fibrillary acidic protein; IBA-1, ionized calciumbinding adaptor molecule
INTRODUCTION
TBI, whether diffuse or focal, produces some level of vascular disruption and local hemorrhage (McGinn and Povlishock, 2015; Salehi et al., 2017) . The ensuing axonal damage and cell death are often associated with these sites of parenchymal vascular insult. Trauma generated rupture of blood cells and hemoglobin breakdown can release heme, which is targeted by HO for proteolysis (Alfieri et al., 2013; Lu et al., 2104 ). This process generates major amounts of free iron within regions of vascular damage, which actively contribute to cytotoxic oxidative insult (Chang et al., 2005) . Clinical assessment of TBI patients revealed increased HO in the cerebral spinal fluid (CSF) of patients with higher injury severity (Cousar et al., 2006) and long-term elevation of HO in affected neurons and glia (Oihara et al., 2003) .
Indeed, recent advances in MRI technology suggest that even mild TBI can generate iron deposition through both heme processing pathways and abnormal iron release from intracellular binding/transport proteins (Nisenbaum et al., 2014) . The HO response to TBI involves two forms of the enzyme, inducible HO-1 and constitutive HO-2. While HO-2 expression level is maintained throughout the postinjury interval (Chang et al., 2003) , HO-1 is the form which is selectively activated by CNS pathology and shows clear time-dependent features (Nitti et al., 2018) . Moreover, the differential cellular expression of HO-1 and HO-2 points to distinct roles for the two isoforms after brain or spinal cord injury (Chang et al., 2005) . HO-1 is upregulated within reactive glia and infiltrating macrophages as a function of injury stimuli, while neurons mount a HO-2 response that is stable over time postinjury. Near the injury site, HO-1 cleaves extravasated heme at the alpha-methene bridge to generate CO, iron, and Biliverdin. Its chief route of induction is through this heme breakdown pathway, which releases reactive oxygen species capable of activating HO-1 transcriptional promoter Nrf2 (Miller et al., 2014) . HO-1 has a high degree of specificity for heme B, largely derived from hemoglobin, whose catabolic products can be bioactive and cytotoxic (Platt and Nath, 1998; Ryter et al., 2006) .
Early studies with TBI models documented the rapid postinjury induction of HO-1 and its association with cytotoxicity. Fukuda and colleagues (1995) reported HO-1 elevation in the subarachnoid space after severe lateral FPI and in an oxyhemoglobin infusion model of subarachnoid hemorrhage (Turner et al., 1998) . This induction was reproduced using a drug-induced model of blood brain barrier (BBB) breakdown (Richmon et al., 1997) . Each of these studies focused on the acute 24h enzyme response and showed that HO-1 signal was selective for reactive glia or infiltrating macrophages, and not visible within injured neurons, as was observed for HO-2. Interestingly, when lysed blood was infused to simulate CNS hemorrhage, animals with genetic overexpression of antioxidants (e.g., superoxide dismutase) had fewer glia with HO-1 increase than wild type controls (Weinzierl et al., 2002) . Similarly, HO-1 was rapidly increased within reactive glia of the cortex, hippocampus and thalamus after severe lateral FPI (Yi and Hazell, 2005) , and the antioxidant N-acetylcysteine significantly attenuated that response. Thus, HO-1 induction can be correlated with extent of hemoglobin release and FPI pathology, making the enzyme a credible marker for postinjury oxidative stress.
Interestingly, spinal cord contusion in HO-1 +/-mice also revealed an exacerbation of endpoints marking BBB disruption (neutrophil invasion; 4-hydroxynonenal and malondialdehyde lipid peroxidation products) and axon injury (myelin basic protein degradation). Together, these data suggested that HO-1 activation may be the critical step for driving iron-mediated oxidative pathology after TBI (Alfieri et al., 2013; Lu et al., 2104; Oihara et al., 2003) .
More recently, TBI studies examining HO response have used animal models with significant hemorrhagic lesion to accentuate enzyme activation (e.g., weight drop, controlled cortical impact [CCI] , stab wound or cold lesion injury). In the open skull weight drop model, HO-1 was induced within 18h and continued to rise through 4d postinjury, localized to reactive microglia and macrophages surrounding the contusion site (Liu et al., 2013) . Also using the weight drop model, Shi and colleagues (2012) tested the effects of traumatic intracerebral hemorrhage on brain edema by combining blood infusion with the injury. HO-1 was selected as a marker of heme processing and results showed a positive correlation between extent of blood cell lysis and HO-1 induction. A later study focused on time-dependent anti-oxidant gene expression after CCI contusion, sampling both core/penumbra of cortex and hippocampus ipsilateral to injury (Miller et al., 2014) . It found that CCI also stimulated HO-1 as an oxidative stress response, where its transcript was upregulated within 24h and protein peaked at 3d postinjury. As with earlier lateral FPI studies, a major HO-1 response within reactive glia was suggested by the temporal correlation between enzyme and GFAP transcript upregulation. Two other studies using penetrating needle lesion (Park et al., 2008) and cryogenic injury (Sakoda et al., 2008) further supported subacute postinjury  showing that its protein response was dependent upon astrocyte reactivity and transcript induction critical to neuroprotection. Despite these positive data indicating HO-1 processing of heme after TBI, there remains some controversy as to the role of HO-1 vs. HO-2 isoforms.
Specifically, HO-1 induction is temporally correlated with injury onset, while HO-2 is modestly upregulated and stable over time after injury. For example, studies with the CCI model of contusion injury confirmed the rapid HO-1 induction seen with more severe FPI, but also showed that HO-1 response was independent of HO-2; not compensatory in the HO-2KO condition, nor protective against HO-2 related pathology revealed in the KO. Remarkably, very little is known regarding the postinjury time course of HO-1 response following diffuse TBI or the key intracellular pathways it pairs with to affect outcome under those conditions. Given that heme processing and iron removal evolves over weeks postinjury, it is necessary to understand how time-dependent HO-1 induction relates to iron transport and sequestration molecules that manage the toxic effects of intracellular heme breakdown.
To better define the postinjury profile of HO-1 and critical iron regulating proteins, we have used the moderate midline FPI model. This diffuse injury elicits only moderate BBB disruption, permitting within animal comparison of HO-1 pathways at sites of overt hemorrhagic damage (neocortex) and adjacent non-hemorrhagic vascular insult (hippocampus). Multiple FPI experiments have demonstrated correlation between increasing injury pressure and widespread diffuse hemorrhage, with the cerebral cortex and underlying white matter tracts demonstrating earlier hemorrhagic susceptibility compared to the hippocampus (Dixon et al., 1987) . In pilot studies with this FPI model, we subjected 24h postinjury neocortical tissue (with established gray/white interface hemorrhage) to Affymetrix gene chip assay for effect on HO and related transcripts, comparing them with sham control transcripts. Results (unpublished) showed a significant upregulation of transcripts for HO-1 (3.8X), iron transport protein LCN2 (34.2X) and MMP9 (2.3X). There was no effect of injury on HO-2 mRNA. These results point to a concerted HO-1 injury response involving iron trafficking proteins and matrix enzymes. LCN2 is an iron trafficking protein which contributes to the acute inflammatory response after injury, where it captures siderophore bound iron for transport and processing (Flower, 1996) . This function is supported by a study with lateral FPI model, where the presence of iron chelator deferoxamine attenuated acute postinjury upregulation of LCN2 (Zhao et al., 2016b) . Interestingly, a cleaved form of nascent LCN2 selectively binds and persistently activates MMP9, a matrix enzyme that can reduce tissue integrity and exacerbate the effects of brain hemorrhage caused by ischemia, stroke or TBI Seo et al., 2012; Wang et al., 2000) . Furthermore, the induction of functional Nrf2 by oxidative insult is correlated with increased MMP9 expression (Saw et al., 2014) . Prior studies have also shown that inflammation induces parallel upregulation of bothLCN2 and FTL (Ni et al., 2015) . FTL is a canonical iron storage protein critical to cell homeostasis (Winter et al., 2014) and upregulated after brain injury (Wu et al., 2003; Natale et al., 2003; Nairz et al., 2017) . Indeed, FTL may serve as a biomarker of cell damage in cases of asymptomatic TBI (Antonopoulos and Kadoglou, 2016) . This pairing of LCN2 and FTL response is consistent with the fact that both proteins are major regulators of iron overload from heme degradation (Pantopoulos et al., 2012) , and that elevated serum FTL is correlated with enhanced inflammatory response (Suchdev et al., 2017) . Indeed, the level of CSF and serum FTL was reported as a predictor of patient death after severe TBI (Simon et al., 2015; Ondruschka et al., 2018) . Of interest, a recent in vitro study showed that chronic exposure of mixed glial cultures to iron overload produced a fivefold increase in microglial FTL (Angelovaand Brown, 2018) .
From these data we hypothesized that diffuse TBI will induce time-dependent HO-1, FTL and LCN2/MMP9 pathway activation at sites of overt postinjury hemorrhage, a response which would be attenuated or absent in brain regions without evidence of vascular disruption.
Using the moderate midline FPI model, postinjury intervals of 1-15d were assessed for HO-1, LCN2 and FTL protein expression, as well as MMP9 proteolytic activity. Sampling contrasted neocortical areas adjacent to hemorrhagic damage with those from non-hemorrhagic hippocampus. Temporal changes in protein expression were mapped to local vasculature and reactive glia through parallel immunohistochemical labeling. Given that activators of HO are being evaluated as a novel therapy for neurodegenerative disease and hemorrhagic stroke (Alfieri et al., 2013; Lu et al., 2104; Ahuja et al., 2016) , defining HO pathway response after diffuse TBI would permit application of these drugs under less stringent pathological conditions, where full resolution of vascular disruption may be possible.
RESULTS

FPI induces time-dependent heme processing and HO-1 induction
In order to map potential differences in cortical heme processing, we initially compared the overall extent of hemorrhage within the grey-white matter interface and hippocampus. At 1, 3 and 7d after FPI, brain sections were examined for presence of brown Bilirubin pigment, while iron accumulation was assessed with blue Perl's stain. As previously reported (Dixon et. al., 1987; Schmidt and Grady, 1993) , multiple sites of hemorrhage, both with and without necrosis, were visible within the corpus callosum and overlaying somatosensory grey matter during the first week postinjury, while the hippocampus failed to show overt hemorrhagic sites ( Figure 1A ). Based on published data linking HO-1 with glia (Fukuda et al., 1995; Fukuda et al., 1996; Mautesand Noble, 2000) and documented reactivity of microglia at sites of vascular disruption (Cao et. al. 2016; Lu et al, 2001; Yamauchi et al., 2004; Lin et al., 2007) , we first probed areas of grey and white matter bleeds with antibodies to HO-1 and microglial marker IBA-1 ( Figure 1B ). At 3d, HO-1 was localized to cells surrounding the necrotic core of the injury, some of which were co-labeled with IBA-1. Vessels adjacent to the core also contained HO-1 positive cells, including evidence of enzyme signal within local microglia. By 7d, when Bilirubin is cleared from corpus callosum, HO-1 signal was reduced and often limited to vascular sites.
Next, protein expression was analyzed in neocortical and hippocampal tissue after necrotic white matter had been removed, providing a comparison between cortex with smaller areas of identifiable vascular disruption and apparently hemorrhage-free hippocampus. When probed for HO-1 expression, we found evidence of significant enzyme induction between 1 and 15d postinjury (Figure 2 ). Increase in HO-1 expression over Sham control values peaked for both neocortex and hippocampus at 3d after injury (1317± 218%, p< 0.01; 2036± 589%, p<0.01, respectively). However, the two brain regions differed in HO-1 response for the remaining time points sampled. At 1d after FPI, neocortex showed over 5 fold rise in HO-1 production (555.5± 57.3%, p <0.05), while hippocampus had modest, but variable expression that failed to prove significant (228.1± 49.9%, n.s.). Interestingly, an opposite regional response occurred at 7d, where there was variable HO-1 expression in the neocortex that did not reach significance(236.8±41.9%, n.s.), yet a 234.2± 32.8%rise in hippocampal HO-1 relative to Sham controls was observed to be significant(p<0.05). By 15d after FPI, a small, but significant HO-1 elevation remained in the neocortex (137.5± 10.9%, p<0.05), but hippocampal enzyme was no longer different from control level (141.2±10.9%, n.s.). Together, these data show that FPI causes a time-dependent cycle of heme processing in areas with overt hemorrhage, where HO-1 is induced acutely in cells near core bleeds and around local affected vessels. This acute cellular response involves reactive microglia within both gray and white matter. There is also a time-dependent HO-1 induction which occurs non-hemorrhagic regions, consistent with the time course of heme processing. Overall, these data correlate with the delayed postinjury peak of HO-1 expression seen in other models of hemorrhagic injury (Cao et al., 2016 , Lu et al., 2001 . It is notable that while the neocortex has higher 1d expression and clear vascular injury, peak expression reaches its greatest level in the hippocampus which lacks overt hemorrhage.
2.2 HO-1 shows region-specific glial induction after FPI We next used IHC to map HO-1 localization within reactive microglia and astrocytes as a function of injury and region. Based upon protein expression time course, we focused on postinjury intervals 1, 3 and 7d using IBA-1 and GFAP as markers for glial cell type. In both neocortex and hippocampus, HO-1 could be localized within microglia and astrocytes, however, this expression differed depending on proximity to either hemorrhagic site or local vasculature. While some microglial cells near the neocortical bleed core were positive for HO-1, other cells did not show co-localization (see again Figure 1B ). However, in the hemorrhagic region adjacent to this core, HO-1 was more prominently induced in reactive astrocytes rather than microglia (Figure 3 ). This response was most evident at 3d postinjury when protein levels of neocortical HO-1 peaked, and was reduced by 7d when blot signal was not different from Sham controls (see again Figure 2 ). Interestingly, co-localization in the non-hemorrhagic hippocampus was also observed, with microglial HO-1 expression at 1d postinjury in the dentate hilus, and astrocyte HO-1 labeling within dentate molecular layer (Figure 4) . At 3d after FPI we found the strongest HO-1 labeling as both cellular and diffuse tissue signal, consistent with the maximal hippocampal 3d protein increase. By 7d postinjury, modest hippocampal HO-1 was restricted to a subset of astrocytes in the outer molecular layer, likely contributing to the small, but significant 7d rise in HO-1 blot signal. From these IHC data, we conclude that postinjury HO-1 induction occurs predominantly within the reactive glia at sites apart from the bleed core, including regions typically identified as the neocortical injury penumbra, and within the non-hemorrhagic hippocampus. Microglia appear to play a lesser role in enzyme response relative to reactive astrocytes. These HO-1 changes in the hippocampus are consistent with the documented glial response in both the dentate hilus and molecular layers (Lin and Wen, 2013; Kelley et al., 2007) . It is striking that hippocampal glia contribute to a 3d HO-1 protein increase comparable to that of neocortex, which exhibits significant hemorrhagic lesions.
2.3 LCN2 induction correlates with heme processing and MMP activation after FPI Transport of iron released from hemoglobin lysis is part of the local inflammatory response to hemorrhagic lesion. After FPI, siderophore-bound iron can be captured by LCN2
and transported between cells for sequestration and recycling. Acute induction of LCN2 expression as part of the innate immune response has been documented after TBI and in models of hippocampal deafferentation (Phillips et al, 2014; Chan et al., 2014; Zhao et al., 2016a, b) . It has also been shown that a cleaved form of nascent LCN2 selectively binds and persistently activates MMP9, a matrix enzyme known to mediate local tissue response at sites of brain hemorrhage Wang et al. 2000; Turner and Sharp 2016) . In order to explore LCN2 role in heme processing after FPI, we next documented the postinjury time course of LCN2 expression, focusing on the 1-7d period ( Figure 5 ). In both neocortex and hippocampus, protein expression analysis revealed a rapid, exceedingly large increase in LCN2 expression at 1d (5845± 1328%, p<0.05; 47486± 9761%, p<0.05, respectively), with the nonhemorrhagic hippocampus nearly 10 fold higher than neocortex. This acute LCN2 response was maintained at 3d in both brain regions, albeit at much reduced levels(618.4± 202.9%, p<0.01; 2893± 975.8%, p<0.01).Again, it was surprising that non-hemorrhagic hippocampal LCN2 remained above control levels at 7d postinjury (128.7±5.6%, p<0.05), when the neocortical level of the protein was no longer different from controls (108.7± 3.2%, n.s.).In order to probe for HO-1 and LCN2 interaction, we used IHC to test for extent of co-localization at 1d after FPI, when LCN2 signal was highest. Results showed co-expression of HO-1 and LCN2 in a subset of cells within the neocortex and in the hippocampal dentate gyrus (Figure 6 ).
While not quantified, it was clear that FPI increased both proteins in a subset of reactive cells.
However, we did find other cells in each brain region with independent upregulation of either HO-1 or LCN2. This pattern does support HO-1/LCN2 interaction after FPI, but also indicates that LCN2 could serve a different postinjury function where it may be increased separately from HO-1.
While both LCN2 and HO-1 show significant increase at 1 and 3d after FPI, peak LCN2 induction at 1d preceded the maximal HO-1 response at 3d. This suggests that 1d LCN2 production might also serve a role different from that of iron transport due to HO-1 processing of hemoglobin. We posited that this high, acute LNC2 increase could be related to its role in regulating MMP9 activity at sites of vascular insult. Evidence from other CNS insult models support such binding of pro-MMP9 to LCN2, stabilizing and persistently activating the enzyme (Bolignano et al., 2010; Chakraborty et al., 2012; Bouchet and Bauvois, 2014; Lee et al., 2015) .Moreover, this type of enzyme regulation occurs even when vascular insult is not accompanied by disruptive bleeds (Chan et al., 2014) . To test this possibility, we ran gelatin zymograms with the same protein extracts used for blot analysis at 1, 3 and 7d postinjury ( Figure 7 ). Results showed up to a 15 fold increase in MMP9 proenzyme activity and a 3 fold rise in activated enzyme function at 1d after FPI. This temporal correlation between acute increase in LCN2 and MMP9 regulation was observed in both hemorrhagic neocortex (1305.9± 179.2%, p<0.001; 339.6± 43.2%, p<0.001, pro/active respectively) and in the non-hemorrhagic hippocampus (1485.9± 219.3%, p<0.001; 257.7± 24.9%, p<0.001, pro/active respectively). By 3d after injury, when LCN2 expression was attenuated, inducible pro-MMP9 activity was no longer increased within neocortex (116.8± 38.5%, n.s.) or hippocampus (194.4± 28.7%, n.s.).
However, lytic function of active MMP9 remained elevated above controls in both neocortex and hippocampus (172.0± 25.5%, p<0.05 and 175.0± 31.3%, p<0.05, respectively). At one week postinjury, activity of both pro-and active MMP9was at control baseline in neocortex and hippocampus (103.2± 17.1%,114.2± 10.9%;101± 6.5%, 124± 20.7% all n.s., respectively).
Zymography also permits assay of the second prominent gelatinase, MMP2, which is not associated with LCN2 binding and activation. As a control for MMP9 specific LCN2 interaction, we observed that MMP2 activity was not temporally correlated with LCN2 induction, where both neocortex and hippocampus showed similar postinjury activity increases of up to 2 fold at 1 (147.9± 2.41%; 153.2± 5.2%, respectively), 3 (180.5± 13.2%; 200.9± 3.7%, respectively) and 7d (181.2± 10.4; 164.4± 7.6%, respectively), all p<0.01. Together, these data support the hypothesis that LCN2 serves at least two important roles after FPI. At acute postinjury intervals its induction can provide both initial iron transport around bleed sites and regulation of MMP9 function. With subsequent periods of maximal HO-1 production, LCN2 can also retain moderately elevated levels, likely affecting iron transport when hemoglobin processing is significantly increased.
Delayed FTL induction correlates with maximal HO-1 heme processing activity
Once HO-1 induction has driven significant hemoglobin breakdown, intracellular FTL is mobilized to store and provide controlled release of accumulated iron (Ryter et al., 2006; Eisenstein et al., 1991; Wu et al., 2003) . In order to evaluate the integration of this principal iron storage protein and HO-1 in response to FPI, we mapped FTL expression over the 1-15d postinjury period. As predicted, induction of FTL was delayed relative to LCN2, showing its first significant postinjury increase in tandem with peak HO-1 level (Figure 8 ). WB analysis revealed that acute 1d FTL protein expression was not different from Sham controls for neocortex (94.9± 19.6%, n.s.) but did show a trend toward early increase in the hippocampus, (163.2± 27.7%, p=0.057). By 3d, the two brain regions showed nearly identical FTL elevation (205.8± 26.0%, p=0.05; 202.0± 43.7%, p<0.05, respectively), suggesting onset of iron storage protein induction as HO-1 rises to generate free iron. Interestingly, FTL showed a highly variable signal for neocortex at 7d postinjury, but was not significantly different from control measures (377.1± 82.1%, n.s.), returning to near Sham baseline at 15d (136.4± 12.80%, n.s.).However, the early rise in hippocampal FTL was maintained at both 7 and 15d (290.6± 54.1%, p<0.05; 237.1± 67.6%, p<0.05). To better understand the time-dependent tissue distribution of FTL and LCN2, we conducted IHC at 3 and 7d postinjury in hippocampus and neocortex ( Figure 9 ). In these experiments we focused on vascular areas which would be primary sites of HO-1 induction. Results showed cellular and diffuse FTL and LCN2 signal around affected vessels in both brain regions, but with minimal co-localization. However, the pattern of labeling over time postinjury confirmed induction of each iron sequestering protein around vasculature at 3d, with lower LCN2 and higher FTL signal by 7dpostinjury. This pattern of expression supports the predicted dual iron binding role during the 3d height of HO-1 function, and a delayed FTL-independent role in long-term iron storage after FPI.
DISCUSSION
The present study documents HO-1 response in a midline FPI model of diffuse injury without severe tissue damage or contusion, comparing regions affected by defined bleeds (neocortical tissue adjacent to gray/white hemorrhage) and those not experiencing visible hemorrhage (hippocampus). We show that time-dependent induction of heme processing enzyme HO-1 occurs with or without overt hemorrhage, and is associated with postinjury increase of iron transporting LCN2 and iron sequestrating FTL. This response is consistent with ongoing heme processing and extracellular matrix modification by MMP9. Our interpretation of how HO-1 pathway proteins might contribute to the evolution of cellular response to FPI is illustrated in Figure 10 . Within the neocortex, vessels are immediately permeabilized after injury, releasing blood cells into the brain parenchyma, an event accompanied by proteolysis of basement membranes and surrounding extracellular matrix.
This induces glial reactivity at the site, occurring in tandem with diffuse axonal injury. To support these changes, HO-1 and LCN2 are rapidly induced, along with acute rise in MMP9 activity. Maximal LCN2/MMP9 response might be predicted due to local tissue effects, but increase in HO-1 would be moderate, since release of heme substrate does not peak until the subacute period. In the latter interval, vascular disruption is extensive and vessel degeneration releases large amounts of heme for HO-1 processing. LCN2 induction here is reduced, directed toward iron transport rather than additional MMP9 activation. The subacute postinjury interval also shows an increase of FTL for processing the copious iron generated by HO-1 heme lysis. Local reactive glia likely source these proteins and mediate neuronal degeneration. By contrast, acute vessel permeability is absent in the postinjury hippocampus, however, injury does induce deafferentation, accompanied by significant elevation of MMP9 and LCN2. With time, presynaptic degeneration ensues, promoting reactive glia that produce HO-1, LCN2 and MMP9. Interestingly, FTL is also persistently increased over this time frame. These subacute protein elevations are remarkably similar to those of injured neocortex, suggesting that hippocampal vessels undergo a progressive, attenuated permeabilization after FPI, possibly in the form of micro hemorrhages capable of inducing HO-1 pathway proteins. Understanding this time course predicts targets for improving clearance of toxic byproducts associated with vascular damage and fostering reorganization in areas capable of repair.
HO-1 induction after diffuse FPI occurs irrespective of hemorrhage detection
The initial experiments of the present study used blot methods to determine the postinjury time course of HO-1 induction following diffuse FPI. Our quantitative protein analysis purposefully avoided sampling of areas containing visible bleeds or necrotic clots, focusing on molecular expression in areas having potential for recovery. Thus, HO-1 response to FPI could be directly compared between neocortex and hippocampus without confounding tissue degeneration. Overall, we found that diffuse FPI induced HO-1 in both hemorrhagic adjacent and non-hemorrhagic regions between 1-3d postinjury, peaking at 3d, followed by a return to control levels by 7-15d. This neocortical HO-1 induction was consistent with processing of heme release from extravasated red blood cells, marked by the progressive appearance of bilirubin and iron pigment over time. For the hippocampus, a similar maximal HO-1 induction at 3d occurred, but without evidence of overt hemorrhage or increase in the bilirubin and iron pigment markers of hemolytic pathology. From the present study we conclude that diffuse FPI promotes an early activation of HO-1 in neocortex, a region subject to overt hemorrhage, where the enzyme is elevated over 12 fold by 3d postinjury and rapidly resolved. This early onset and rapid resolution of HO-1 response would be predicted given the attenuated vascular disruption and tissue damage of diffuse FPI relative to the more severe models of brain injury. Nevertheless, it is striking that the adjacent hippocampus, a brain region with no overt hemorrhage, exhibits a slightly delayed and even higher HO-1 induction.
While hippocampal HO-1 was not significantly induced at 1d postinjury, it did show a 3d peak in expression as with neocortex. Thus, while HO-1 can be predictably induced in the presence of overt hemorrhage, injured areas without significant hemolytic pathology can also show a similar time course of HO-1 activation. Perhaps the simplest explanation of this unexpected hippocampal response is that the region is vulnerable to undetected micro bleeds sufficient to induce HO-1. New imaging technology tracking iron accumulation supports this possibility, showing that previously undetected micro hemorrhages are more common throughout the injured brain (Nisenbaum et al., 2014) . Further, the delayed hippocampal onset of HO-1 response also suggests that its activation can be influenced by the evolution of local cell injury and vascular insult, or circulating vascular signals originating from distal hemorrhagic brain regions.
The pattern of acute HO-1 induction after diffuse FPI was similar to that reported for other TBI models, but the timing and extent of expression varies as a function of model severity and sampling interval. For example, our results do agree with a 1d postinjury induction and high 3d HO-1 expression initially reported for cortex and hippocampus after moderate lateral FPI (Fukuda et al., 1995; Fukuda et al., 1996) . However, with a more severe lateral FPI, cortical HO-1 expression increased within 18h, and continued to rise until 7d postinjury (Sato and Noble, 1998) , likely due to increased vascular damage and HO-1 substrate at the trauma site. Similarly, cortical HO-1 showed a progressive increase between 18h and 4d postinjury after the severe impact of the weight drop model of TBI (Liu et al., 2013) .
Interestingly, the CCI model of cortical contusion failed to show significant increase in HO-1 protein at 1d postinjury, with onset delayed until 2d, and a peak induction at 7d after trauma (Miller et al., 2014) . It is important to note that, for all of these studies hemorrhagic cores were not excluded from tissue sampling, and protein expression within the regions surrounding the bleed site was not specifically targeted. Here, we report that diffuse FPI elicits a multifold HO-1 rise within the injured neocortex by 1d postinjury, which peaked at 3d, and returned to control level by 7d. This temporal pattern might be explained by the timing of erythrocyte phagocytosis and hemoglobin release after diffuse FPI, a process mediated by erythrocyte cell surface receptor CD47 (Oldenborg et al., 2000) . Published studies show that collapse of extravasated erythrocytes begins early after a cerebral bleed and peaks at 3d, a response paired with CD47 loss and HO-1 elevation (Schallner et al., 2015) . Therefore, HO-1 induction after diffuse FPI appears correlated with tissue signals linked to the time course of hemoglobin release at hemorrhagic sites. As expected, if heme is a major driver of HO-1 induction, when the more severe weight drop model was combined with intracerebral hemorrhage induction, Shi and colleagues (2012) found that blood extravasation exacerbated the 3d HO-1 response.
Interestingly, a recent study mapping HO-1 expression following blast TBI, also showed that mRNA and protein peak at 3d within the injured frontal pole and hippocampus, concurrent with activation of HO-1 transcription factor Nrf2 (Zhou et al., 2019) . Thus, irrespective of insult intensity and degree of vascular damage, there appears to be a prominent HO-1 response occurring between 3-4d after injury. However, this response may remain elevated for a longer period of time when there is significant tissue damage or ongoing vascular disruption. The fact that diffuse, non-contusion FPI generates significant HO-1 induction across broad brain regions suggests that understanding how heme processing pathways respond to TBI will have significant therapeutic value, even in regions without pathologic hemorrhage.
Tissue localization of HO-1 following diffuse FPI pointed to postinjury activation in reactive glia. This pattern is in agreement with the mixed microglial and astrocyte HO-1 response seen 1-3d after lateral FPI (Fukuda et al., 1995; Fukuda et al., 1996; Sato and Noble, 1998; Yi 2005) , CCI (Chang et al., 2003 , Miller et al., 2014 , weight drop insult Shi et al., 2012) and stab or cold injury (Park et al., 2008; Sakoda et al., 2008) . After diffuse FPI we also observed a 3d peak of HO-1 label within reactive glia, consistent with the time course of enzyme expression. This pattern occurred in both hemorrhagic and nonhemorrhagic regions. In the neocortex, HO-1 expression varied as a function of time and distance from the hemorrhage. Reactive microglia showed rapid, persistent rise of HO-1 around the necrotic core and in adjacent reactive vessels. This would be predicted given the active mobility of microglia following brain injury (Donat et al., 2017; Karve et al., 2016) and the induction of microglial HO-1 in response to inflammatory signals (McCarthy et al., 2018) .
By contrast, HO-1 response was prominent within the reactive astrocyte population distal to the bleed. There we observed dilated vessels, suggestive of the increased permeability produced with TBI pathology and continued vascular disruption (DeWitt and Prough, 2003; Kenney et al., 2016; Chodobski et al., 2011) . At sites of neurovascular unit compromise, HO-1 signal was first detected in local astrocytes, which, over time, appeared within cell bodies and processes of activated astrocytes. Similarly, we found spatial-temporal differences in glial HO-1 expression within the injured hippocampus. Early HO-1 signal occurred within microglia of the dentate hilus and in astrocytes adjacent to the granule cell layer, zones documented to show prominent HO-1 expression in normal brain (Vincent et al., 1994) , and elevated neuronal injury biomarkers following midline FPI (McGinn and Povlishock, 2015) . As time postinjury progresses, HO-1 signal becomes prominent within reactive astrocytes of the outer molecular layer and surrounding the vessels of the hippocampal fissure, before resolving to match controls by 7d. Interestingly, these temporal patterns of glial HO-1 suggest a common spatial response to diffuse FPI across brain regions. It appears that necrotic hemorrhage in the neocortex and sub lethal neuronal insult in the hippocampus each prompt acute microglial HO-1 induction proximal to the initial cellular pathology. With time, astrocytes distal to these areas are affected by this pathology and begin to show onset of HO-1 expression.
3.2 HO-1, iron management and tissue matrix pathways coincide after FPI A second goal of our study was to define the temporal response of iron management proteins induced by diffuse FPI in both hemorrhagic and non-hemorrhagic regions. Based upon the postinjury evolution of bilirubin and Perl's iron expression, we focused on the downstream induction of FTL over the 1-15d period for which we mapped HO-1 activation. We found that the iron sequestration protein was elevated by 3d postinjury in the neocortex, matching the interval of maximal HO-1 signal, then peaks at 7d (barely missing significance) and returns control level by 15d after FPI. This response was predicted based upon the pattern reported during hemorrhage recovery of other vascular disruption models (O'Shaughnessy et al., 1966; Strassmann, 1949; Wu et al., 2003) . The delay in FTL peak in this region is consistent with the time period required for accumulation of free iron within cells that are actively processing heme, and parallels reported fivefold FTL elevation within cultured microglia exposed to high iron concentration (Angelova and Brown, 2018) . Interestingly, we also found FTL induction within the non-hemorrhagic hippocampus after FPI. Here the iron sequestering protein showed a 1d trend toward elevation, earlier than in the neocortex, and maintained a 2-3 fold rise up to 15d after injury. This result is more difficult to interpret relative to HO-1 upregulation. First, hippocampal HO-1 did not significantly change at 1d postinjury, when FTL appeared to show effects of FPI. Moreover, FTL remained elevated over two weeks after injury, during the time HO-1 returned to control level. These results might be explained in at least three ways. First, given that TBI can generate widespread vascular leakiness (DeWitt and Prough, 2003; Kenney et al., 2015; Chodobski et al., 2011) , and that the uninjured dentate gyrus can support low level HO-1 upregulation (Vincent et al., 1994) , it is possible that limited quantities of released heme are processed in the postinjury hippocampus and FTL recruited even during periods with little HO-1 change in tissue relatively less damaged. To this point, our 7d IHC showed high FTL signal around vessels of the hippocampal fissure, a time point with low HO-1 expression. Alternatively, the acute rise and persistent upregulation of hippocampal FTL might be a consequence of constitutive HO-2 response rather than heme processing specific to HO-1. Indeed, HO-2 is upregulated 1d after CCI both ipsilateral and contralateral to the site of trauma (Chang et al., 2003) , suggesting that it responds to a generalized vascular permeability, which we posit may be occurring in postinjury hippocampus. Finally, it is possible that ongoing mitochondrial dysfunction within injured hippocampal neurons permits release of cytochrome heme, which would be processed by HO and induce chronic FTL upregulation. This scenario is supported by clinical data reporting that TBI patients with contusion have rapid neuronal FTL induction linked to increased mitochondrial damage (Liu et al., 2013) . Further, when FTLmitoKO mice were subjected to CCI, the loss of mitochondrial FTL buffering of intracellular iron exacerbated vascular disruption, oxidative stress and neurological deficits (Wang et al., 2017) .
In order to better understand the early iron sequestration that occurs after FPI, we also mapped postinjury response of LCN2, an iron management protein found in cells that express FTL, and a mediator of cellular iron trafficking (Flower, 1996; Ratledge, 2007; Nairz et al., 2007) . Since this siderophore-binding, iron transport protein is highly reactive during acute postinjury intervals (Zhao et al., 2016a, b; Huang et al., 2016; Flower, 1996) , we focused on its response over the first week after FPI. It is possible that initial neuronal insult compels the release of 'help me' signals like LCN2 to recruit stabilizing support from local glia (Xing et al., 2014) . We found a similar overall time course of LCN2 induction for hemorrhagic neocortex and non-hemorrhagic hippocampus. Maximal induction occurred at 1d after FPI, with significant attenuation by 3d, and movement toward control values by 7d. This time course was consistent with other reports of LCN2 reactivity to CNS trauma (Chan et al., 2014; Zhao et al., 2016a,b; Huang et al., 2016; , showing extraordinarily high LCN2 induction 1d after injury. For example, in the hemorrhagic neocortex, a 500 fold LCN2 induction over sham controls suggests that the protein is critical to the rapid capture and transport of free iron from the interstitial space across cell membranes for sequestration.
Thus, massive LCN2 iron movement into cells at 1d would likely initiate intracellular FTL upregulation as early as 3d postinjury, which we did observe with blot analysis. Further, IHC at 3d postinjury revealed clear LCN2 signal around injured vessels alongside strong FTL induction in cells targeting the adjacent clot. Notably, LCN2 elevation occurs prior to HO-1 peak, indicating that initial injury produces both rapid iron release, as well as a slower intracellular iron accumulation due to subsequent erythrophagocytosis and heme processing. Indeed, our IHC at 1d supports this interpretation, since only a subset of LCN2+ reactive glia showed co-expression of HO-1 at 1d after FPI. While we did not perform experiments to confirm glial cell type for this co-expression, based upon morphology, prior paired staining experiments, and the fact that LCN2 can mediate cell transformation during reactive astrocytosis (Lee et al., 2009), we posit that these LCN2 and HO-1 positive cells are astrocytes.
A similar pattern of acute postinjury LCN2 protein induction was observed for hippocampus, however, the increase was one tenth that of neocortex and remained significantly higher than controls between 3-7d postinjury. Given that we failed to observe hippocampal hemorrhage, but did see HO-1 induction within reactive glia, we posit that LCN2 serves a dual role in this region, not only supporting transport of HO-1 produced iron, but also mediating the reshaping of tissue matrix and BBB due to FPI pathology. To assay this additional LCN2 role, we measured postinjury activity of MMP9, a matrix enzyme induced by hemorrhage and whose activity can be regulated by LCN2 (Bolignano et al., 2010; Chakraborty et al., 2012; Bouchet and Bauvois, 2014) .
Initially described as a neutrophil gelatinase-associated lipocalin, LCN2 covalently binds MMP9 (Gelatinase B) to form a complex that can enhance gelatinase activity by preventing MMP9 proteolytic recycling (Flower et al., 1996; Bolignano et al., 2010) . The enzyme exists in a pro-form, which can be regulated through inhibitory control of its cleavage to the active state. Pro-MMP9 is highly inducible during the acute postinjury period following a variety of CNS insults (Kyrkanides et al., 2001; Lekic et al., 2011; Rosenberg et al., 2001; Gasche et al., 1999; Szklarczyk et al., 2002) . This acute upregulation is principally associated with its role in modification of the local environment around hemorrhagic sites within the brain parenchyma and its influence on BBB integrity. After ischemia and TBI, induction of MMP9 is correlated with LCN2 elevation and the presence of bound LCN2/MMP9 complex (Park et al., 2009; Phillips et al., 2014; Chan et al., 2014) . As with LCN2 response to diffuse FPI, we found that MMP9 activation was highest at 1d postinjury for both neocortex and hippocampus. Moreover, the level of pro-MMP9 was increased up to 15 fold at the same time point. By 3d after FPI, proenzyme was no longer different from controls, but active MMP9 still retained a reduced, but significant increase. Further, the fact that injury-induced upregulation of MMP2 (Gelatinase A) activity was not time-dependent in either brain region reinforces the relationship between LCN2 and MMP9. This temporal correlation suggests that diffuse FPI, with or without hemorrhage, activates MMP9 in the acute postinjury phase, likely involving stabilization in that form by upregulated LCN2. Such results would be predicted for the neocortex, where vascular bleeds fit the stroke prototype of rapid MMP9 response after damage to the neurovascular unit (Turner and Sharp, 2016) . It is also reported that when acute inflammation is attenuated, marked by the loss of cytokine osteopontin, hippocampal MMP9 activity and LCN2/MMP9 complex formation are reduced (Chan et al., 2014) . Such LCN2/MMP9 interaction may be dependent on injury model and inflammatory condition. For example, in mice where immune response is dysregulated by loss of ATF3 transcription factor, the weight drop insult induces higher transcription of LCN2 and MMP inhibitor TIMP1, but fails to change MMP9 transcript (Forstner et al., 2018) . In that case LCN2 upregulation may preferentially occur in response to a larger hematoma and serve to address elevated iron management versus matrix modification. Thus, even with non-contusion FPI, the acute postinjury induction of HO-1, LCN2 and MMP9 suggests a time-dependent relationship between heme processing, iron transport and extracellular matrix reorganization. Our results also reveal that LCN2 can be recruited as a multifaceted response to diffuse FPI, targeting iron management in conjunction with HO-1, and neurovascular unit regulation through MMP9.
Heme processing and the management of post-injury hemorrhage
Traditional therapy for injury related hemorrhage sought to first stop active bleeds, thereby preventing further tissue damage and permitting successful reperfusion or to evacuate rapidly expanding hematomas to prevent intracranial mass effects (LeRoux, 2013; Kobata, 2017; Iorio-Morin et al., 2018; Lin et al., 2017; Peres et al., 2017) . Added interest in how heme is processed after hemorrhagic insult has now raised the possibility that the pathway might be manipulated to improve post-injury outcome (Zhao et al., 2006; Alfieri et al., 2013) . While targeting heme pathways after the major bleeding of stroke is straightforward, the same approach has potential to improve outcome after TBI (Dash et al., 2009; Zhang et al., 2013; Zhao et al., 2016b) . Although considered part of secondary insult after diffuse FPI, the present results make it clear that both HO-1 and iron regulatory proteins respond during postinjury intervals amenable to therapeutic targeting. Moreover, the documented activation for these proteins occurs within tissue spaces where recovery is possible.
One method of targeting heme processing would be to induce earlier and higher postinjury levels of HO, facilitating more rapid breakdown and sequestration of iron prior to significant build up around the hemorrhagic sites. This approach has been used in stroke and ischemia models with some success, where transcription factor Nrf2 was targeted to upregulate HO-1 and antioxidant mRNA (Ren et al, 2011; Alfieri et al., 2013; Lu et al., 2014; Zhang et al., 2014; Ashabi et al., 2105; Chen-Roetling and Regan, 2017) . With increased HO-1 translation, these studies showed reduced hemorrhagic area, less BBB disruption and improved functional outcome. In the present study, we have documented a delay in HO-1 peak induction until 3d after diffuse FPI. Since this interval is concurrent with maximal erythrocyte breakdown and hemoglobin release, an extended postinjury window for HO gene manipulation exists. Given that Nrf2 targeted effects on HO-1 transcription mapped to the same 2-3d postinjury interval (Miller et al., 2014) , therapeutic strategies includingHO-1 mRNA elevation have been reported. For example, successful improvement in cognitive outcome after CCI was described with acute postinjury sulforaphane administration, releasing KEAP inhibition and nuclear mobilization of Nrf2 to facilitate antioxidant and HO-1 gene expression (Zhao et al, 2007; Dash et al., 2009; Hong et al., 2010) .
A second approach for increasing HO-1 response would be to introduce exogenous hemin into the vasculature, providing increase of HO-1 substrate at sites of brain hemorrhage prior to 3d postinjury peak of enzyme induction. This approach could permit an acute 'jump start' to gene induction of HO-1. An earlier rise in heme processing would be synchronous with maximal 1d postinjury LNC2 elevation for iron transport, and could also shift FTL expression for iron storage to earlier time points. Together, elements of heme processing pathways might operate earlier and at a higher level to minimize the negative effects of free iron and other toxic byproducts. Indeed, a few studies have tested this type of heme administration after spinal cord injury, ischemia and intracerebral hemorrhage (Yamauchi et al., 2004; Zhang et al., 2013; Lu et al., 2014) , showing protection of BBB and attenuated vascular disruption.
Finally, the present study shows that the hippocampus exhibits postinjury induction of heme processing pathway molecules, even without evidence of overt hemorrhage. Future studies utilizing more powerful MRI techniques may very well expose numerous hippocampal micro hemorrhages or broad vascular leakiness. It is possible that signals from these pathologies could be responsible for activating heme processing proteins in brain regions heretofore considered free from vascular injury. Nevertheless, the fact that hippocampal induction of HO-1 and LCN2 after diffuse FPI was remarkably similar to hemorrhagic neocortex suggests that multiple heme pathway proteins might serve as therapeutic targets after TBI. Since cognitive deficits associated with hippocampal injury are a hallmark of TBI (Paterno et al., 2017) , limiting tissue damage and cell death through manipulation of LCN2 and FTL response should improve functional outcome (Xing and Lo, 2017; Kelly-Cobbs et al., 2013) . Given these multiple options for targeting HO-1 and other molecules associated with heme processing pathways, we predict future studies will reveal that elevated structural and functional protection can be achieved by simply shifting the time course of activation for these proteins after brain injury.
Conclusions
This study demonstrates that the limited vascular pathology associated with diffuse midline FPI is sufficient to induce multifold induction of HO-1 and iron regulatory proteins LCN2 and FTL. Moreover, this response occurs at a similar scale within brain regions which do not show signs of overt hemorrhage. Consistent with contusional models of TBI, reactive glia are principal sites for heme processing pathway activation, with some cell type selectivity depending upon distance from bleeds or injury-induced cell damage. Acute HO-1 and LCN2 induction are temporally correlated with MMP9 activation, a predicted mediator of vascular permeability at sites of injury. These data support a broad postinjury window for therapeutic intervention targeting the pathological effects of iron and other toxins produced by traumatic vascular disruption.
EXPERIMENTAL PROCEDURES
Experimental Animals
All procedures met national guidelines for care and use of laboratory animals, and all experimental protocols were approved by the VCU Institutional Animal Care and Use Committee. Male Sprague-Dawley rats (290-360g; Harlan Laboratories) were housed in pairs under a temperature (22ºC) and humidity (66%) controlled environment, with food and water ad libitum, and subjected to a 12h dark-light cycle. Rats (n=47) were randomly selected and subjected to moderate midline FPI. Sham-injured cases served as controls. Subsets of FPI and sham-injured groups were allowed to survive for either 1, 3, 7 or 15d post-injury prior to molecular or histological analysis (see Figure Legends for specific group numbers).
Surgery Preparation and Injury
Rats were anesthetized with isoflurane (4% in 70% N 2 O, 30% O 2 carrier gas) and maintained on 2% isoflurane in carrier gas delivered by nose cone. Once stabilized in a stereotaxic frame, body temperature was maintained at 37ºC by Gaymar T/Pump water pump (Gaymar Industries Inc., Orchard Park, NY) and physiological signs monitored by pulse oximetry (MouseOx; Starr Life Sciences, Oakmont, PA). Rats received a midline 4.8 mm craniectomy, centered between bregma and lambda. Without damaging the underlying dura, a modified Leur-Loc syringe hub (2.6 mm i.d.) was fitted over the craniotomy, fixed in place using cyanoacrylate and anchored by steel screws stabilized with dental acrylic. Topical anesthetic/antibiotic was applied to the incision site and rats monitored during the acute recovery phase before returning to home cages.
At 24 hrs. after hub placement, rats were anesthetized for 4 mins (4% isoflurane, 70% N 2 O, 30% O 2 ), and subjected to mild-moderate level midline fluid percussion injury (FPI) by the method previously described (Dixon et al., 1987; . The device consisted of a 60 x 4.5 cm Plexiglas water filled cylinder, fitted at one end with a piston mounted on Orings, with the opposite end housing a pressure transducer (EPN-0300A; Entran Devices, Inc., Fairfield, NJ). At the time of injury, the Leur-Loc fitting filled with saline was attached to the transducer housing. Injury was produced by a metal pendulum striking the piston, transiently injecting a small volume of 0.9% saline into the cranial cavity and briefly deforming the brain tissue (20 msec duration). The resulting pressure pulse was recorded extra cranially and registered 2.0±0.1 atm overpressure. After injury, all rats were ventilated with room air until spontaneous breathing resumed. The duration of suppression of the righting reflex (7.0±2.0 mins) was used as an index of traumatic unconsciousness. Once righting reflex was determined, animals were re-anesthetized for hub removal, scalp suture and topical anesthetic/antibiotic application. Sham-injured controls received the same surgical preparation, anesthesia and connection to the injury device, except that the intracranial pressure pulse was not applied. All rats were returned to their home cages and assessed for weight loss, locomotion, and eye/nose exudate once per day until weights stabilized.
Protein Extraction
Rats were anaesthetized with 4% isoflurane in carrier gas of 70% N 2 O, 30% O 2 for 4 min, then sacrificed by decapitation at 1, 3, 7 or 15d after FPI or sham injury. Tissue blocks of somatosensory neocortex and whole hippocampi were excised bilaterally. Sites containing tissue necrosis were excluded from each sample. For the neocortex, this generated samples exhibiting vascular bleeds without confounding tissue degeneration. Samples were homogenized on ice in 250 µl of RIPA Lysis Buffer (EMD Millipore, Billerica, MA) containing cOmplete protease inhibitor + EDTA, and centrifuged at 14,000 x g for 20 min at 4°C.
Supernatant was aliquoted and stored at -80°C. Prior to WB analysis, protein concentration was determined using Pierce BCA Protein Assay Reagent (Thermo-Fisher, Waltham, MA) and the FLUOstar Optima plate reader (BMG Labtech, Inc., Cary, NC).
Western Blotting
Western Blot (WB) analysis was carried out utilizing Bio-Rad products (Hercules, CA) according to prior published methods (Chan et al., 2014; Powell et al., 2018) WB images were captured with Syngene G: Box and band signal subjected to densitometric analysis (relative optical density, ROD) with Gene Tools software (Syngene, Frederick, MD).
Protein data were expressed as percent change relative to time-matched Sham control cases run on the same transferred gel. Beta actin (Sigma-Aldrich, St. Louis, MO) was used as a load control.
Zymography
Zymographic enzyme assay was performed using previously described methods (Harris et al, 2012; Chan et al., 2014) . Briefly, 20 µg of protein from the somatosensory neocortex and whole hippocampus extracts used for WB were prepared with 2x Tris-glycine SDS sample 
Immunohistochemistry
At 3, 7 and 21d postinjury survival, rats were prepared for fluorescent immunohistochemical (IHC) analysis according to published protocol (Warren et al., 2012) .
Animals were anaesthetized with sodium pentobarbital (400mg/kg, i.p.), transcardially perfused with 0.9% saline followed by 4% paraformaldehyde in phosphate buffer (0.1M NaHPO 4 , pH=7.4), after which brains were extracted and placed in fixative for 24 h before transfer to 0.03% NaN 3 in 1.0 M phosphate buffered saline (PBS). For IHC, tissue was blocked and sectioned into 40 um coronal slices using a Leica Vibratome (VT1000S; Leica Biosystems 
Perls' Stain
The evolution of postinjury iron deposition was evaluated using Perls' Prussian Blue staining (Simmons et al., 2007; Castellani et al., 2016) . This method permits the morphological detection of Fe (II, III) hexacyanoferrate within brain tissue, which maps the time course of iron deposition and aggregation following FPI. Briefly, fixed tissue sections of whole rat brains were re-hydrated and treated with a freshly prepared acid ferrocyanide solution (5% potassium ferrocyanide, 5% hydrochloric acid) for 30 mins at RT. Sections were then subjected to three 5 min washes with distilled water, dehydrated, cleared and mounted on glass slides. Blue Fe signal was examined using a wide field Olympus BX51 microscope Sham n=4, 6, 4, 8/group (1, 3, 7, 15d, respectively); FPI n=6, 7, 5, 8/group (1, 3, 7, 15d, respectively) . TBI. Sham n=4, 6, 3, 8/group (1, 3, 7, 15d, respectively); FPI n=6, 7, 5, 8/group (1, 3, 7, 15d, respectively) . 
